Texas Gov. Greg Abbott on June 11 signed a bill creating a consortium of universities, hospitals and pharmaceutical firms to conduct clinical trials on on ibogaine, in hopes of receiving US Food & Drug Administration approval. The press release on the signing hails ibogaine as an "emerging treatment for neurological and mental health conditions." Lawmakers approved $50 million to support the effort, making Texas the global leader in psychedelic research investment. (Texas Tribune)
Recent comments
2 weeks 5 days ago
6 weeks 6 days ago
7 weeks 6 days ago
7 weeks 6 days ago
29 weeks 3 hours ago
33 weeks 1 day ago
34 weeks 5 days ago
34 weeks 6 days ago
47 weeks 1 day ago
1 year 5 days ago